Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.459 SEK | +2.00% | -3.27% | -12.24% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Analyst Reco.
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Analyst Reco.